ANNUAL GENERAL MEETING OF Q-MED AB (publ)

Report this content

The Annual General Meeting of Q-Med AB (publ) was held on May 3, 2007 at 3 p.m. on Q-Med’s new premises, which are entered from Fyrisvallsgatan 5, Uppsala.

Dividend
The meeting decided that a dividend of 2 SEK per share shall be paid to shareholders.

Board and fees
The meeting decided to re-elect the following members of the Board, Håkan Edström, Bertil Hult, Anders Milton, Pia Rudengren, Åsa Rödén, Pernilla Ström och Bengt Ågerup for the period up until the end of the next Annual General Meeting.

The meeting also re-elected Pia Rudengren as the Chair of the Board.

The meeting also decided that Board fees of 1,050,000 SEK in total be paid for the period 2007/2008, with 300,000 SEK to the Chair of the Board and 150,000 SEK to each of the other members of the Board, except for Bengt Ågerup, who is an employee of the company and shall therefore not receive a Board fee, which means unchanged fees compared with the previous year.

Auditors’ fees shall be paid in accordance with reasonable invoicing.

A fee of 180,000 SEK in total shall be paid for work on the audit committee, to be divided among the three members as follows: 90,000 SEK to the Chair of the committee and 45,000 SEK to each of the other two committee members.

Election committee
The Annual General Meeting decided that the election committee shall continue to consist of three members and re-elected Robert Wikholm as Chair with the assignment of finding, at the latest during the third quarter, two representatives from the major owners to be included in the election committee, and that a fee of SEK 60,000 be paid to the election committee, to be allocated in accordance with the decision of the election committee. This is an unchanged fee compared with the previous year.

Principles for remuneration
Finally, the meeting decided on principles for remuneration and other conditions of employment for senior management in accordance with the proposal of the Board.

Queries should be addressed to:
Madelene Sandgren, Director Investor Relations and Corporate Communications
Tel: 070-974 90 15

Documents & Links